Health Discovery Corp (HDVY)

[dollardaze]

Evaluating Results???... Wonder Whats Really Going On
HDC 10K Filed 3/31/11:
We continue to progress towards the goal of commercialization of the 4-gene urine-based prostate cancer test at Quest and with Abbott Upon completion of development and validation to the satisfaction of Quest, the 4-gene urine test for prostate cancer can be immediately commercialized as an LDT under the current CLIA regulations. Upon regulatory approval, Abbott could immediately begin commercialization and sale of the individual In-VitroDiagnostic (IVD) test kits to additional national, regional and local clinical laboratories, as well as hospital, academic and physician laboratories around the world.

HDC 10Q Filed 5/16/11:
Please refer to our Annual Report on Form 10-K filed on March 31, 2011 for further information regarding updates with our business.

HDC 10Q Filed 8/15/11:
We continue to progress towards the goal of commercialization of the 4-gene urine-based prostate cancer test at Quest and with Abbott. The clinical trials for both Abbott and Quest studies have been completed and the Company is currently in the process of evaluating the results with Abbott and Quest.